BIO/PhRMA JOINT FDA REFORM MEASURE GOES TO BIO BOARD FOR APPROVAL DURING WEEK OF JULY 24; BIO TO FORWARD BILL TO CAPITOL HILL IN SEVERAL WEEKS
Executive Summary
The Biotechnology Industry Organization is expected to seek board approval of a joint FDA reform proposal being developed by BIO and the Pharmaceutical Research & Manufacturers of America during the week of July 24.